Variation in optimal hemodynamic atrio-ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics.
atrioventricuar delay
cardiac resynchronization therapy
endocardial left ventricular lead
heart failure
hemodynamic optimization
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
revised:
11
01
2023
received:
15
06
2022
accepted:
05
02
2023
medline:
12
6
2023
pubmed:
15
2
2023
entrez:
14
2
2023
Statut:
ppublish
Résumé
It is not known whether the optimal atrioventricular (AV We assessed the hemodynamic AV Seventeen patients were included (12 male, aged 66.5 ± 12.8 years, ejection fraction 26 ± 7%, 16 left bundle branch block or high percentage of right ventricular pacing [RVP], QRS duration 167 ± 27 ms). In most locations (62/63), AV Within a patient, different endocardial LV lead locations have slightly different hemodynamic AV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1431-1440Informations de copyright
© 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
Références
Kyriacou A, Li Kam Wa ME, Pabari PA, et al. A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy. Int J Cardiol. 2013;167(3):954-964.
Sohaib SMA, Kyriacou A, Jones S, et al. Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant. Europace. 2016;17(12):1823-1833.
Derval N, Jaïs P. Optimizing hemodynamics in cardiac resynchronization therapy by left ventricular pacing site. JACC. 2010;56(10):782-783.
Spragg DD, Dong J, Fetics BJ, et al. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy. JACC. 2010;56(10):774-781.
Reddy VY, Miller MA, Neuzil P, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing. JACC. 2017;69(17):2119-2129.
Whinnett ZI, Davies JER, Willson K, et al. Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart. 2006;92(11):1628-1634.
Whinnett ZI, Davies JER, Willson K, et al. Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure. EP Europace. 2006;8(5):358-366.
Francis DP. Precision of a parabolic optimum calculated from noisy biological data, and implications for quantitative optimization of biventricular pacemakers (Cardiac Resynchronization Therapy). Appl Math. 2011;02(12):1497-1506.
Brabham WW, Gold MR. The role of AV and VV optimization for CRT. J Arrhythm. 2013;29(3):153-161.
Whinnett ZI, Sohaib SMA, Mason M, et al. Multicenter randomized controlled crossover trial comparing hemodynamic optimization against echocardiographic optimization of AV and VV delay of cardiac resynchronization therapy. JACC: Cardiovasc Imaging. 2019;12:1407-1416.
Kindermann M, Erohlig G, Doerr T, Schieffer H. Optimizing the AV delay in DDD pacemaker patients with high degree AV block: mitral valve Doppler versus impedance cardiography. Pacing Clin Electrophysiol. 1997;20:2453-2462.
Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845-1853.
Cleland JGF, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539-1549.
Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy. JACC. 2012;59(17):1509-1518.
Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the speckle tracking assisted resynchronization therapy for electrode region trial. Circ. Heart Fail. 2013;6(3):427-434.
Sohaib SMA, Whinnett ZI, Ellenbogen KA, et al. Cardiac resynchronisation therapy optimisation strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing. Int J Cardiol. 2013;170(2):118-131.
Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation. 2010;122(25):2660-2668.
Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017;38(10):730-738.
Birnie D, Lemke B, Aonuma K, et al. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. Heart Rhythm. 2013;10(9):1368-1374.
Raphael CE, Kyriacou A, Jones S, et al. Multinational evaluation of the interpretability of the iterative method of optimisation of AV delay for CRT. Int J Cardiol. 2013;168(1):407-413.
van Gelder BM, Bracke FA, Meijer A, Pijls NHJ. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. JACC. 2005;46(12):2305-2310.
Derval N, Steendijk P, Gula LJ, et al. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites. JACC. 2010;55(6):566-575.
Sohaib SMA, Shun-Shin MJ, Wright I. Using high precision haemodynamic measurements to assess differences in AV optimum between different left ventricular lead potions in biventricualr pacing. European Heart Rhythm Association; 2017.
Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368(17):1585-1593.
Zweerink A, Salden OAE, van Everdingen WM, et al. Hemodynamic optimization in cardiac resynchronization therapy. JACC: Clin Electrophysiol. 2019;5(9):1013-1025.